← Back to Search

THRIVE Intervention for Suicide Crisis (THRIVE Trial)

N/A
Recruiting
Led By Jennifer Lockman, PhD
Research Sponsored by Centerstone Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

THRIVE Trial Summary

This trial will study a new, 60-minute, technology-based intervention called THRIVE, which may help people in a suicide crisis reduce suicidal ideation and increase their recovery.

Who is the study for?
This trial is for English-speaking residents of Davidson County who are at increased risk for suicide and have been admitted to a Crisis Stabilization Center. Participants must be able to give informed consent, provide contact information for follow-ups, and discuss their suicidal thoughts or attempts. Those acutely psychotic or unable to communicate with the research team cannot join.Check my eligibility
What is being tested?
The study tests THRIVE, a new 60-minute recovery-oriented intervention using narrative and technology, against usual care in Crisis Stabilization Centers. It aims to see if THRIVE can better help individuals understand their suicide crisis, reduce suicidal thoughts, and support recovery.See study design
What are the potential side effects?
Since THRIVE is a psychological intervention rather than a medication, it may not have typical 'side effects' but could potentially cause emotional discomfort when discussing sensitive topics like suicide.

THRIVE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hopefulness
Meaning made of stress
Self-efficacy to avoid suicidal action

THRIVE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental: THRIVE + Usual CareExperimental Treatment2 Interventions
Individuals presenting to a community-based crisis stabilization center who are age 18-plus and screen positive for suicide risk
Group II: Usual CareActive Control1 Intervention
Individuals presenting to a community-based crisis stabilization center who are age 18-plus and screen positive for suicide risk
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Usual Care
1990
Completed Phase 4
~7700
THRIVE
2017
N/A
~420

Find a Location

Who is running the clinical trial?

University of RochesterOTHER
840 Previous Clinical Trials
534,100 Total Patients Enrolled
17 Trials studying Suicide
89,710 Patients Enrolled for Suicide
Centerstone Research InstituteLead Sponsor
3 Previous Clinical Trials
1,642 Total Patients Enrolled
1 Trials studying Suicide
162 Patients Enrolled for Suicide
Jennifer Lockman, PhDPrincipal InvestigatorCenterstone Research Institute

Media Library

THRIVE Clinical Trial Eligibility Overview. Trial Name: NCT05558891 — N/A
Suicide Research Study Groups: Experimental: THRIVE + Usual Care, Usual Care
Suicide Clinical Trial 2023: THRIVE Highlights & Side Effects. Trial Name: NCT05558891 — N/A
THRIVE 2023 Treatment Timeline for Medical Study. Trial Name: NCT05558891 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the uppermost limit on participants in this medical experiment?

"Affirmative. According to clinicaltrials.gov, this research project is actively recruiting participants; the trial was initially posted on June 22nd 2022 and most recently updated on November 21st 2022. The team requires 150 individuals from a single medical site for their study."

Answered by AI

Is enrollment for this experiment still open?

"This medical trial is actively searching for participants, as indicated by the clinicaltrials.gov webpage. It was initially posted on June 22nd 2022 and has been updated most recently on November 21st of the same year."

Answered by AI
~12 spots leftby Jun 2024